Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.6B and CN¥274.5M respectively. Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd's EBIT is CN¥46.7M making its interest coverage ratio -4.3. It has cash and short-term investments of CN¥1.0B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -4.3x |
| Cash | CN¥1.04b |
| Equity | CN¥2.35b |
| Total liabilities | CN¥274.50m |
| Total assets | CN¥2.63b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1349's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥265.8M).
Long Term Liabilities: 1349's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥8.7M).
Debt to Equity History and Analysis
Debt Level: 1349 is debt free.
Reducing Debt: 1349 has no debt compared to 5 years ago when its debt to equity ratio was 14.9%.
Debt Coverage: 1349 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1349 has no debt, therefore coverage of interest payments is not a concern.